Company intelligence / Profile preview

National Drug Biologic Research Company

Ownership: Private
Development stage: Other

Overview

National Drug Biologic Research Company was a historical entity involved in the research and development of biological products and pharmaceuticals. The company focused on early-stage drug discovery and the development of biologics for various therapeutic applications, including infectious diseases. While it operated within the life sciences sector, it is no longer an active commercial entity in the modern biotech landscape. Its legacy is primarily associated with early efforts in biological research and drug standardization.

Therapeutic areas: OncologyInfectious Diseases
Modalities: BiologicSmall molecule
Industry: Academic Hospital/University/Research

Beyond the preview

Go deeper on National Drug Biologic Research Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on National Drug Biologic Research Company.

Explore the full profile